• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹腔内注射链球菌制剂OK-432对腹膜癌的抗肿瘤作用:I. 大鼠实验研究

Antitumor effect in peritoneal carcinomatosis of intraperitoneal administration of a streptococcal preparation, OK-432: I. Experimental study in the rat.

作者信息

Saji S, Umemoto T, Kida H, Sakata K

出版信息

J Surg Oncol. 1985 Sep;30(1):46-51. doi: 10.1002/jso.2930300113.

DOI:10.1002/jso.2930300113
PMID:4079418
Abstract

The effect of intraperitoneal OK-432 administration and its mechanism of action were investigated using an experimental rat tumor. On day 4 or 6 of intraperitoneal inoculation of tumor cells, 50 Klinische Einheit (KE)/kg of OK-432 was intraperitoneally administered, and intraperitoneal exudate cells were microscopically examined daily. Distribution of peritoneal exudate cells: A marked increase in neutrophils was noted in ascites at 24 hours after intraperitoneal administration of OK-432, with macrophages and lymphocytes appearing later than neutrophils. A subsequent decrease in neutrophils was accompanied by a gradual increase in tumor cells. Findings of tumor cells: When OK-432 was intraperitoneally administered on day 4 of tumor inoculation, aggregation of neutrophils around tumor cells was observed on day 6, and rosette formations around tumor cells were noted on day 7 or 8. Subsequently tumor cells that formed the centers of the rosettes were destroyed and disappeared. These reactions were not observed when OK-432 was administered on day 6, nor were they observed in untreated cases. These results suggest that cytotoxic effects of intraperitoneally administered OK-432 were displayed mainly by rosette formation by neutrophilic cells, as far as this model was concerned.

摘要

使用实验性大鼠肿瘤研究腹腔注射OK-432的效果及其作用机制。在腹腔接种肿瘤细胞后的第4天或第6天,腹腔注射50临床单位(KE)/kg的OK-432,并每天对腹腔渗出细胞进行显微镜检查。腹腔渗出细胞的分布:腹腔注射OK-432后24小时,腹水中中性粒细胞显著增加,巨噬细胞和淋巴细胞比中性粒细胞出现得晚。随后中性粒细胞减少,同时肿瘤细胞逐渐增加。肿瘤细胞的观察结果:在肿瘤接种第4天腹腔注射OK-432时,第6天观察到肿瘤细胞周围有中性粒细胞聚集,第7天或第8天观察到肿瘤细胞周围有花环形成。随后形成花环中心的肿瘤细胞被破坏并消失。在第6天注射OK-432时未观察到这些反应,在未治疗的病例中也未观察到。就该模型而言,这些结果表明腹腔注射OK-432的细胞毒性作用主要通过嗜中性细胞形成花环来体现。

相似文献

1
Antitumor effect in peritoneal carcinomatosis of intraperitoneal administration of a streptococcal preparation, OK-432: I. Experimental study in the rat.腹腔内注射链球菌制剂OK-432对腹膜癌的抗肿瘤作用:I. 大鼠实验研究
J Surg Oncol. 1985 Sep;30(1):46-51. doi: 10.1002/jso.2930300113.
2
[Antitumor effect of intraperitoneal administration of a streptococcal preparation, OK-432, in carcinomatous peritonitis. I. Experimental study in the rat].[腹腔注射链球菌制剂OK-432对癌性腹膜炎的抗肿瘤作用。I. 大鼠实验研究]
Gan To Kagaku Ryoho. 1982 Nov;9(11):1961-8.
3
Mechanism of immunotherapeutic activity of OK-432 in the treatment of peritoneal carcinomatosis.溶链菌(OK-432)治疗腹膜癌病的免疫治疗活性机制。
Cancer Immunol Immunother. 1989;29(1):1-6. doi: 10.1007/BF00199909.
4
New approach to management of malignant ascites with streptococcal preparation OK-432. III. OK-432 attracts natural killer cells through a chemotactic factor released from activated neutrophils.用链球菌制剂OK-432治疗恶性腹水的新方法。III. OK-432通过活化中性粒细胞释放的趋化因子吸引自然杀伤细胞。
Surgery. 1990 Jan;107(1):74-84.
5
Anti-tumor effects of the oral administration of the streptococcal preparation OK-432 (PICIBANIL)--the inhibition of carcinogenesis and growth in rats with ENNG-induced gastrointestinal tumors.口服链球菌制剂OK-432(皮西巴尼)的抗肿瘤作用——对乙基亚硝基脲诱导的大鼠胃肠道肿瘤致癌作用和生长的抑制
Jpn J Surg. 1990 May;20(3):316-26. doi: 10.1007/BF02470667.
6
Mechanism of induction of endogenous tumor necrosis factor in ascites of ovarian cancer patients by OK-432, a streptococcal preparation.链球菌制剂OK-432诱导卵巢癌患者腹水中内源性肿瘤坏死因子的机制
Immunopharmacol Immunotoxicol. 1989;11(1):33-53. doi: 10.3109/08923978909082141.
7
[Antitumor activity of neutrophils induced by a nonspecific immunopotentiator OK-432. I. Experimental study using a rat model of malignant ascites].[非特异性免疫增强剂OK-432诱导的中性粒细胞的抗肿瘤活性。I. 使用恶性腹水大鼠模型的实验研究]
Nihon Gan Chiryo Gakkai Shi. 1988 Jun 20;23(6):1229-35.
8
New approach to management of malignant ascites with a streptococcal preparation, OK-432. II. Intraperitoneal inflammatory cell-mediated tumor cell destruction.用链球菌制剂OK-432治疗恶性腹水的新方法。II. 腹膜内炎症细胞介导的肿瘤细胞破坏。
Surgery. 1983 Mar;93(3):365-73.
9
Antitumor effect of the streptococcal preparation OK-432 in a murine model of ovarian cancer.链球菌制剂OK-432在小鼠卵巢癌模型中的抗肿瘤作用。
Cancer Immunol Immunother. 1987;24(2):172-7. doi: 10.1007/BF00205596.
10
[Intraperitoneal administration of OK-432 and rIL-2 in a case of peritonitis carcinomatosa with chronic renal failure].[腹腔内注射OK-432和重组白细胞介素-2治疗一例伴有慢性肾衰竭的癌性腹膜炎]
Nihon Gan Chiryo Gakkai Shi. 1990 May 20;25(5):1027-31.